Stockscreener 앱 받기
0.00
100.00%
-0.5746
시간 외 거래:
.60
0.60
+
Kineta Inc 주식(KA)의 최신 뉴스
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerML, HURA, KANT, VTS - AccessWire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc.HURA - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders - GlobeNewswire
TuHURA Biosciences, Inc. entered into a non-binding agreement to acquire Kineta, Inc. from Craig Philips and others for $30 million. - Marketscreener.com
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kineta, Inc.KANT - PR Newswire
TuHURA Biosciences to Acquire Kineta - citybiz
KANT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kineta, Inc. Is Fair to Shareholders - The Bakersfield Californian
HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders - Business Wire
TuHURA Biosciences to Acquire Kineta, Inc. in 2025 - TipRanks
Kineta Merges with TuHURA to Enhance Cancer Treatment - TipRanks
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc. - Sacramento Bee
TuHURA Biosciences to Acquire Kineta, Adding Promising Phase 2 Cancer Immunotherapy to Pipeline - StockTitan
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression - StockTitan
Kineta and TuHURA Enter Acquisition Agreement - TipRanks
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell... - Markets Insider
ARMISTICE CAPITAL, LLC Acquires New Stake in Kineta Inc - GuruFocus.com
Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024) - The Manila Times
BioWorld Cancer Index continues to decline amid broader market gains - BioWorld Online
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
Codexis to Report Third Quarter 2024 Financial Results on October 31 - The Manila Times
Delisting of Securities of Gamer Pakistan Inc.; Biotricity, Inc.; Zalatoris II Acquisition Corp.; Warrantee Inc.; Spectaire Holdings, Inc.; Centogene N.V.; DZS Inc.; Corner Growth Acquisition Corp. 2; Collective Audience, Inc.; Grom Social Enterprises Inc.; Fintech Ec - ForexTV.com
Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors - The Manila Times
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta - AsiaOne
Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024 - The Manila Times
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1 - ForexTV.com
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta's VISTA blocking antibody Currently in Phase 1 - The Manila Times
Kineta Inc (KA-Q) QuotePress Release - The Globe and Mail
United States shares lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
Chemotherapy Induced Anemia Drug Industry Growth Factors, Applications, and Forecast by (2024-2034) - Daily News Mirror
Short Interest in Kineta, Inc. (NASDAQ:KA) Drops By 99.3% - Defense World
Chemotherapy Induced Peripheral Neuropathy Treatment Market Insights Discussed Regarding Report 2024: Size,... - WhaTech
Kineta shares to be delisted from Nasdaq By Investing.com - Investing.com Australia
Kineta shares to be delisted from Nasdaq - Investing.com
Kineta, Inc Transitioning from Nasdaq to OTC Markets - ForexTV.com
Kineta transitions from Nasdaq to OTC markets - TipRanks
KA’s Stochastic Averages Dip: Analyzing Kineta Inc’s Stock Performance - The InvestChronicle
Chemotherapy Induced Peripheral Neuropathy Treatment Market Size, Innovations Driving Market Evolution (2024-2034) – La Funcion mx - La Funcion mx
Closing Figures: Kineta Inc (KA)’s Negative Finish at 0.57, Down -30.69 - The Dwinnex
Bishop Kiengei’s ex hilariously asks him to throw daughter bash, tags his wife - Tuko.co.ke
NickelX Directors Bolster Investment Amid Compliance Update - TipRanks
StockNews.com Upgrades Kinross Gold (NYSE:KGC) to Strong-Buy - Defense World
Kinross Gold (NYSE:KGC) Sees Unusually-High Trading Volume - Defense World
Popular Asian fusion eatery closes permanently due to power outage issues - MSN
Kalana Ispat Limited IPO Opens On September 19, 2024 - ANI News
Specialty Insurer Kinsale Set To Keep Up Its Strong Growth (NYSE:KNSL) - Seeking Alpha
You might want to take a look at Kinross Gold Corp. (KGC) now - SETE News
'Footpath to nowhere' a recipe for disaster, says principal - Northern Advocate
Jefferies gives a Hold recommendation for Kinross Gold Corp. (KGC) - Knox Daily
Kalana Ispat Limited Set to Launch IPO on September 19, 2024 - Devdiscourse
SHOCK as it emerges Kilimani OCPD supervised the demolition of Kikao Place in Lavington after getting intelligence reports that the owner was selling hard drugs. - DAILY POST
Indo National pares 51% stake in Kineco for ₹220 Crore - Indiainfoline
Analyzing Ikena Oncology (NASDAQ:IKNA) & Kiromic BioPharma (NASDAQ:KRBP) - Defense World
Kinsale Capital Group (NYSE:KNSL) Stock Rating Lowered by Wolfe Research - Defense World
GISB restaurant employees deny accusations of placing “foot and beard water” in food - theSun
'Pleasant surprise' as former Tikipunga Tavern site becomes 55 state homes - New Zealand Herald
Kin returning for a season three 'looking less and less likely' - Head Topics
0.08%
0.05%
자본화:
|
볼륨(24시간):